John F. Beeler

784 citations

20 papers · 657 indexed · h-index 11

Co-authors: T Miki Kazushige Sakaguchi M. Tachibana Yoshihiro Horii Mohammad A. Heidaran William J. LaRochelle Jacalyn H. Pierce Stuart A. Aaronson
Topics: Protein Kinase Regulation and GTPase Signaling (6 papers)Lung Cancer Treatments and Mutations (6 papers)Cancer Genomics and Diagnostics (5 papers)
Cited by: Cancer Research Cell Biology Oncology
Journals: Journal of Biological Chemistry Journal of Clinical Oncology The EMBO Journal
Partner nations: United States France Spain

In The Last Decade

John F. Beeler

19 papers receiving 642 citations

Peers

Countries citing papers authored by John F. Beeler

Since Specialization

Citations

This map shows the geographic impact of John F. Beeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Beeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Beeler more than expected).

Fields of papers citing papers by John F. Beeler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. Beeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Beeler. The network helps show where John F. Beeler may publish in the future.

Co-authorship network of co-authors of John F. Beeler

This figure shows the co-authorship network connecting the top 25 collaborators of John F. Beeler. A scholar is included among the top collaborators of John F. Beeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Beeler. John F. Beeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis 2025 ·Blood ·(unknown),Pu Zhang,Xiangyu Pan,Cynthia Aparecida de Castro,(unknown),Alexander M. Lewis,(unknown),(unknown),(unknown),(unknown),John F. Beeler,Duc Tran,(unknown),Catrina C. Fronick,Konrad H. Stopsack,Carlos Cruchaga,Omar Abdel‐Wahab,Kelly L. Bolton	0
2	New Technologies to Image Tumors 2020 ·Cancer treatment and research ·George McNamara,Justin Lucas,John F. Beeler,Ajay Basavanhally,George Lee,Cyrus V. Hedvat,Vipul Baxi,Darren Locke,Alexander D. Borowsky,Richard M. Levenson	4
3	Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer 2019 ·Lung Cancer ·Nicolas Guibert,Greg Jones,John F. Beeler,Vincent Plagnol,Clive Morris,Jean Mourlanette,Myriam Delaunay,Laura Keller,Isabelle Rouquette,Gilles Favre,Anne Pradines,Julien Mazières	78
4	Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer. 2019 ·Journal of Clinical Oncology ·Nicolas Guibert,Greg Jones,John F. Beeler,Clive Morris,Vincent Plagnol,Jean Mourlanette,Myriam Delaunay,Isabelle Rouquette,Gilles Favre,Anne Pradines,Julien Mazières	10
5	P1.01-46 Circulating Tumor DNA Analysis for Predicting Response to Osimertinib and Disease Progression in EGFR-Mutant Non-Small-Cell Lung Cancer 2018 ·Journal of Thoracic Oncology ·(unknown),Liqiang Xi,Constance M. Cultraro,(unknown),Nitin Roper,Mohammadhadi Bagheri,Arun Rajan,John F. Beeler,(unknown),Mark Raffeld,Udayan Guha	2
6	Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer 2018 ·Annals of Oncology ·Nicolas Guibert,Yuebi Hu,Nora Feeney,Yanan Kuang,Vincent Plagnol,(unknown),Karen Howarth,John F. Beeler,Cloud P. Paweletz,Geoffrey R. Oxnard	89
7	Early prediction of outcomes to PD1 inhibitors in non-small cell lung cancer (NSCLC) using next generation sequencing (NGS) of plasma circulating tumor DNA (ctDNA). 2018 ·Journal of Clinical Oncology ·Nicolas Guibert,Greg Jones,John F. Beeler,Vincent Plagnol,Myriam Delaunay,(unknown),Gilles Favre,Anne Pradines,Julien Mazières	2
8	Early trends of ctDNA levels in non-small cell lung cancer patients treated with immunotherapy (CLIP-IT): Pilot study. 2018 ·Journal of Clinical Oncology ·Meera Yogarajah,(unknown),Clive Morris,(unknown),Greg Jones,Anthony Underwood,John F. Beeler,Paul R. Walker	1
9	Cloning and characterization of the mouse homolog of the human A6 gene 1997 ·Gene ·John F. Beeler,Bharvin K.R. Patel,Márcio F. Chedid,William J. LaRochelle	8
10	A Divalent Metal Ion Binding Site in the Kinase Insert Domain of the .alpha.-Platelet-Derived Growth Factor Receptor Regulates Its Association with SH2 Domains 1995 ·Biochemistry ·(unknown),Narmada Thanki,Pilar Aroca,P McPhie,Jin‐Chen Yu,John F. Beeler,Eugenio Santos,Alexander Wlodawer,Mohammad A. Heidaran	10
11	Regulation of hepatocyte plasma membrane α1-adrenergic receptors by 4β-phorbol 12-myristate 13-acetate 1995 ·Biochemical Journal ·John F. Beeler,RA Cooper	12
12	Prokaryotic Expression Cloning of a Novel Human Tyrosine Kinase 1994 ·Molecular and Cellular Biology ·John F. Beeler,William J. LaRochelle,Márcio F. Chedid,Steven R. Tronick,Stuart A. Aaronson	14
13	Comparison of calcium-dependent conformational changes in the N-terminal SH2 domains of p85 and gap defines distinct properties for SH2 domains 1994 ·Biochemistry ·(unknown),Narmada Thanki,P McPhie,John F. Beeler,Jin Yu,Alexander Wlodawer,Mohammad A. Heidaran	17
14	A novel oncogene, ost, encodes a guanine nucleotide exchange factor that potentially links Rho and Rac signaling pathways. 1994 ·The EMBO Journal ·Yoshihiro Horii,John F. Beeler,Kazushige Sakaguchi,M. Tachibana,T Miki	176
15	Prokaryotic expression cloning of a novel human tyrosine kinase. 1994 ·Molecular and Cellular Biology ·John F. Beeler,William J. LaRochelle,Márcio F. Chedid,Steven R. Tronick,Stuart A. Aaronson	37
16	Stimulation of the Platelet-Derived Growth Factor β Receptor Signaling Pathway Activates Protein Kinase C-δ 1994 ·Molecular and Cellular Biology ·Weiqun Li,(unknown),Paolo Michieli,John F. Beeler,Nelson Ellmore,Mohammad A. Heidaran,Jacalyn H. Pierce	95
17	Rapid and reversible uncoupling of the hepatic α1-adrenergic receptor and guanine-nucleotide-binding protein by phorbol 12,13-dibutyrate 1993 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·John F. Beeler,Ronald H. Cooper	4
18	Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions 1993 ·Journal of Biological Chemistry ·Mohammad A. Heidaran,John F. Beeler,JiaDe Yu,Tomohiko Ishibashi,William J. LaRochelle,Jacalyn H. Pierce,Stuart A. Aaronson	68
19	Characterization of baculovirus-expressed human .alpha. and .beta. platelet-derived growth factor receptors 1992 ·Biochemistry ·Roy A. Jensen,John F. Beeler,Mohammad A. Heidaran,William J. LaRochelle	26
20	Catecholamine depletion and accumulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) in adrenal medullary chromaffin cells 1988 ·Neurochemistry International ·Steven P. Wilson,John F. Beeler	4

About John F. Beeler

John F. Beeler is a scholar working on Cancer Research, Physiology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 657 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Cancer Research (164 citations), Cell Biology (144 citations) and Oncology (177 citations). John F. Beeler has collaborated with scholars based in United States, France and Spain. Frequent co-authors include T Miki, Kazushige Sakaguchi, M. Tachibana, Yoshihiro Horii, Mohammad A. Heidaran, William J. LaRochelle, Jacalyn H. Pierce, Stuart A. Aaronson, Nicolas Guibert and Vincent Plagnol. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact